Cameroon vs Gambia, The: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cameroon
82.0%
in 2025
Gambia, The
82.0%
in 2025
Cameroon rank
104th
Gambia, The rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cameroon
- Gambia, The
How they compare
Cameroon currently reports 82.0% against 82.0% in Gambia, The, a difference of 0.0%.
Across all 18 years both countries report, Gambia, The has been ahead every year.
Cameroon ranks 104th and Gambia, The ranks 104th of 192 countries.
Gambia, The has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Gambia, The | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.2% | 94.6% | 32.4% | Gambia, The |
| 2020s | 73.7% | 79.7% | 6.0% | Gambia, The |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cameroon or Gambia, The?
- Cameroon, at 82.0% against 82.0% in Gambia, The as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cameroon and Gambia, The?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Gambia, The?
- 18 years are reported by both, from 2008 to 2025.
- How do Cameroon and Gambia, The rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cameroon ranks 104th and Gambia, The ranks 104th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.